当前位置:首页 - 行情中心 - 开立医疗(300633) - 财务分析 - 利润表

开立医疗

(300633)

  

流通市值:187.68亿  总市值:187.68亿
流通股本:4.31亿   总股本:4.31亿

利润表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、营业总收入1,467,832,830.331,043,339,390.9473,030,518.351,762,648,981.93
营业收入1,467,832,830.331,043,339,390.9473,030,518.351,762,648,981.93
二、营业总成本1,145,708,757.88761,809,244.07358,549,235.761,419,492,200.01
营业成本459,094,202.17323,627,832.2148,528,324.04584,041,436.64
税金及附加18,203,227.4313,480,320.776,480,792.3215,221,786.31
销售费用352,750,664.36231,504,764.8105,681,831.55423,163,991.07
管理费用84,901,395.3255,375,184.0525,153,021.0997,998,237.43
研发费用263,619,138.72169,796,135.180,009,904.74328,957,726.84
财务费用-32,859,870.12-31,974,992.85-7,304,637.98-29,890,978.28
其中:利息费用4,384,236.653,374,625.551,538,530.233,704,806.13
其中:利息收入21,478,174.5723,777,683.1615,194,145.1917,835,555.36
加:公允价值变动收益-10,823,354.91-16,605,338.683,312,105.93-3,932,049.21
加:投资收益-5,031,538.782,878,894.732,134,750.039,254,370.17
资产处置收益20,353.98-3,963.5320,353.98-744,349.85
资产减值损失(新)-9,040,202.13-9,040,202.13--40,141,025.72
信用减值损失(新)-22,113,007.91-20,433,918.58-7,297,543.87-19,913,976.99
其他收益74,598,997.5852,791,894.0436,777,088.5894,748,572.43
营业利润平衡项目0000
四、营业利润349,735,320.28291,117,512.68149,428,037.24382,428,322.75
加:营业外收入196,542.5850,556.9231,879.36109,425.08
减:营业外支出995,420.78292,102.56283,417.57595,345.53
利润总额平衡项目0000
五、利润总额348,936,442.08290,875,967.04149,176,499.03381,942,402.3
减:所得税费用28,319,29417,816,121.2610,702,112.7412,130,688.56
六、净利润320,617,148.08273,059,845.78138,474,386.29369,811,713.74
持续经营净利润320,617,148.08273,059,845.78138,474,386.29369,811,713.74
归属于母公司股东的净利润320,617,148.08273,059,845.78138,474,386.29369,811,713.74
(一)基本每股收益0.750.640.320.86
(二)稀释每股收益0.740.630.320.86
八、其他综合收益7,212,683.342,010,714.8-623,608.7715,857,886.48
归属于母公司股东的其他综合收益7,212,683.342,010,714.8-623,608.7715,857,886.48
九、综合收益总额327,829,831.42275,070,560.58137,850,777.52385,669,600.22
归属于母公司股东的综合收益总额327,829,831.42275,070,560.58137,850,777.52385,669,600.22
公告日期2023-10-262023-08-232023-04-272023-04-12
审计意见(境内)标准无保留意见
TOP↑